×
S&P 500   3,835.36 (+0.10%)
DOW   30,994.30 (+0.09%)
QQQ   286.80 (-0.06%)
AAPL   142.00 (+0.31%)
MSFT   263.93 (+0.41%)
META   166.45 (-1.03%)
GOOGL   2,247.44 (-0.79%)
AMZN   112.90 (-0.53%)
TSLA   686.99 (-1.75%)
NVDA   150.73 (+0.73%)
NIO   20.96 (-5.50%)
BABA   115.93 (-3.50%)
AMD   74.78 (-0.56%)
MU   57.86 (+1.99%)
CGC   2.64 (-2.58%)
T   21.12 (-0.24%)
GE   61.95 (-0.13%)
F   10.92 (-2.50%)
DIS   96.74 (-0.45%)
AMC   12.53 (-1.96%)
PFE   52.09 (+0.87%)
PYPL   74.00 (-0.54%)
NFLX   182.64 (-1.74%)
S&P 500   3,835.36 (+0.10%)
DOW   30,994.30 (+0.09%)
QQQ   286.80 (-0.06%)
AAPL   142.00 (+0.31%)
MSFT   263.93 (+0.41%)
META   166.45 (-1.03%)
GOOGL   2,247.44 (-0.79%)
AMZN   112.90 (-0.53%)
TSLA   686.99 (-1.75%)
NVDA   150.73 (+0.73%)
NIO   20.96 (-5.50%)
BABA   115.93 (-3.50%)
AMD   74.78 (-0.56%)
MU   57.86 (+1.99%)
CGC   2.64 (-2.58%)
T   21.12 (-0.24%)
GE   61.95 (-0.13%)
F   10.92 (-2.50%)
DIS   96.74 (-0.45%)
AMC   12.53 (-1.96%)
PFE   52.09 (+0.87%)
PYPL   74.00 (-0.54%)
NFLX   182.64 (-1.74%)
S&P 500   3,835.36 (+0.10%)
DOW   30,994.30 (+0.09%)
QQQ   286.80 (-0.06%)
AAPL   142.00 (+0.31%)
MSFT   263.93 (+0.41%)
META   166.45 (-1.03%)
GOOGL   2,247.44 (-0.79%)
AMZN   112.90 (-0.53%)
TSLA   686.99 (-1.75%)
NVDA   150.73 (+0.73%)
NIO   20.96 (-5.50%)
BABA   115.93 (-3.50%)
AMD   74.78 (-0.56%)
MU   57.86 (+1.99%)
CGC   2.64 (-2.58%)
T   21.12 (-0.24%)
GE   61.95 (-0.13%)
F   10.92 (-2.50%)
DIS   96.74 (-0.45%)
AMC   12.53 (-1.96%)
PFE   52.09 (+0.87%)
PYPL   74.00 (-0.54%)
NFLX   182.64 (-1.74%)
S&P 500   3,835.36 (+0.10%)
DOW   30,994.30 (+0.09%)
QQQ   286.80 (-0.06%)
AAPL   142.00 (+0.31%)
MSFT   263.93 (+0.41%)
META   166.45 (-1.03%)
GOOGL   2,247.44 (-0.79%)
AMZN   112.90 (-0.53%)
TSLA   686.99 (-1.75%)
NVDA   150.73 (+0.73%)
NIO   20.96 (-5.50%)
BABA   115.93 (-3.50%)
AMD   74.78 (-0.56%)
MU   57.86 (+1.99%)
CGC   2.64 (-2.58%)
T   21.12 (-0.24%)
GE   61.95 (-0.13%)
F   10.92 (-2.50%)
DIS   96.74 (-0.45%)
AMC   12.53 (-1.96%)
PFE   52.09 (+0.87%)
PYPL   74.00 (-0.54%)
NFLX   182.64 (-1.74%)
NYSE:NRZ

New Residential Investment Price Target, Predictions & Analyst Ratings

$9.55
-0.08 (-0.83%)
(As of 07/6/2022 09:52 AM ET)
Add
Compare
Today's Range
$9.55
$9.79
50-Day Range
$8.25
$11.74
52-Week Range
$8.18
$11.81
Volume
33,695 shs
Average Volume
8.39 million shs
Market Capitalization
$4.46 billion
P/E Ratio
4.23
Dividend Yield
10.47%
Price Target
$12.20

New Residential Investment (NYSE:NRZ) Price Target and Consensus Rating (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 7 Analyst Ratings

Consensus Analyst Price Target

$12.20
27.75% Upside
High Prediction$13.50
Average Prediction$12.20
Low Prediction$10.00
TypeCurrent
7/6/21 to 7/6/22
1 Month Ago
6/6/21 to 6/6/22
3 Months Ago
4/7/21 to 4/7/22
1 Year Ago
7/6/20 to 7/6/21
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
6 Buy rating(s)
8 Buy rating(s)
13 Buy rating(s)
Hold
0 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$12.20$12.60$12.67$11.50
Predicted Upside27.75% Upside12.84% Upside16.05% Upside19.90% Upside
Get New Residential Investment Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NRZ and its competitors with MarketBeat's FREE daily newsletter.


NRZ Stock Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NRZ Stock Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

New Residential Investment Stock vs. The Competition

TypeNew Residential InvestmentFinance CompaniesS&P 500
Consensus Rating Score
2.71
2.52
2.51
Consensus RatingModerate BuyBuyBuy
Predicted Upside26.69% Upside72.83% Upside31.80% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
548
74.05%
Underperform Votes
192
25.95%
Avg. Outperform Votes
150
62.76%
Avg. Underperform Votes
89
37.24%
Avg. Outperform Votes
840
69.08%
Avg. Underperform Votes
376
30.92%

Historical New Residential Investment Price Targets and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/13/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underweight$12.00 ➝ $10.00-8.00%
3/29/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$13.00 ➝ $13.50+24.88%
11/19/2021Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$12.00 ➝ $13.00+16.49%
10/18/2021JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Outperform$11.00 ➝ $11.50+1.23%
10/8/2021Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
H. Coffey
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
9/29/2021Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight
8/30/2021Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$12.00 ➝ $13.00+20.82%
4/21/2021Jonestrading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold
4/16/2021BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$12.00 ➝ $13.00+24.76%
12/18/2020Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$10.50+4.58%
12/14/2020Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$11.00+18.15%
11/24/2020B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Timothy P. Hayes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy$9.50 ➝ $11.50+15.58%
11/6/2020Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform
10/20/2020Compass Point
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$11.00+36.65%
9/24/2020UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$11.00+47.45%
7/27/2020Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kevin Heal
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$10.00+31.41%
2/13/2020Nomura Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$18.50 ➝ $20.00+14.55%
11/14/2019Piper Jaffray Companies
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Neutral$16.00-0.31%
(Data available from 7/6/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












New Residential Investment Price Target - Frequently Asked Questions

What is New Residential Investment's consensus rating and price target?

According to the issued ratings of 7 analysts in the last year, the consensus rating for New Residential Investment stock is Moderate Buy based on the current 1 sell rating and 6 buy ratings for NRZ. The average twelve-month price prediction for New Residential Investment is $12.20 with a high price target of $13.50 and a low price target of $10.00. Learn more on NRZ's analyst rating history.

Do Wall Street analysts like New Residential Investment more than its competitors?

Analysts like New Residential Investment stock more than the stock of other Finance companies. The consensus rating for New Residential Investment is Moderate Buy while the average consensus rating for finance companies is Buy. Learn more on how NRZ compares to other companies.

Do MarketBeat users like New Residential Investment more than its competitors?

MarketBeat users like New Residential Investment stock more than the stock of other Finance companies. 74.05% of MarketBeat users gave New Residential Investment an outperform vote while finance companies recieve an average of 62.76% outperform votes by MarketBeat users.

Is New Residential Investment being downgraded by Wall Street analysts?

Over the previous 90 days, New Residential Investment's stock had 2 downgrades by analysts.

Does New Residential Investment's stock price have much upside?

According to analysts, New Residential Investment's stock has a predicted upside of 10.99% based on their 12-month price targets.

What analysts cover New Residential Investment?

New Residential Investment has been rated by Piper Sandler in the past 90 days.

This page (NYSE:NRZ) was last updated on 7/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.